Kristen K. Buck - 01 Sep 2022 Form 4 Insider Report for CALADRIUS BIOSCIENCES, INC. (LSTA)

Role
EVP, R&D and CMO
Signature
Kristen K. Buck, James Nisco, Attorney-in-Fact
Issuer symbol
LSTA
Transactions as of
01 Sep 2022
Net transactions value
-$5,980
Form type
4
Filing time
02 Sep 2022, 16:05:02 UTC
Previous filing
12 Jan 2022
Next filing
11 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LSTA Common Stock Award $29,000 +58,000 +18% $0.5000* 377,203 01 Sep 2022 Direct F1, F2
transaction LSTA Common Stock Tax liability $12,592 -25,183 -6.7% $0.5000* 352,020 01 Sep 2022 Direct F2, F3
transaction LSTA Common Stock Tax liability $22,388 -44,776 -13% $0.5000* 307,244 01 Sep 2022 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects 58,000 in performance rights, the criteria for which was satisfied on September 1, 2022 and which vested on the same date.
F2 Includes 257,750 of unvested restricted stock.
F3 Shares withheld as payment of a tax liability on vesting of performance rights.
F4 Shares withheld as payment of a tax liability on vesting of restricted stock.
F5 Includes 154,625 of unvested restricted stock.

Remarks:

Exhibit List: Exhibit 24, Power of Attorney.